Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma

Oncology Reports

Volumn 11, Issue 4, 2004, Pages 923-929

  Smardova, Jana ^a   Ksicova, Katerina ^a   Binkova, Hana ^b   Krpensky, Antonin ^b   Pavlova, Sarka ^a   Rottenberg, Jan ^b   Koukalova, Hana ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

FASAY; Head and neck squamous cell carcinoma; Temperature sensitive mutants; Tumor suppressor p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CZECH REPUBLIC; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; YEAST;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CZECH REPUBLIC; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

EID: 16544380605     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.4.923     Document Type: Article

References (37)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999. (Pubitemid 29094960)
3. Wong DT, Todd R, Tsuji T and Donoff RB: Molecular biology of human oral cancer. Crit Rev Oral Biol Med 7: 319-328, 1996. (Pubitemid 27010030)
4. Blons H and Laurent-Puig P: TP53 and head and neck neoplasms. Hum Mutat 21: 252-257, 2003. (Pubitemid 36292966)
5. Hollstein M, Hergenhahn M, Yang Q, Bartsch H, Wang ZQ and Hainaut P: New approaches to understanding p53 gene tumor mutation spectra. Mutat Res 431: 199-209, 1999. (Pubitemid 30017791)
6. Hainaut P and Hollstein M: p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77: 81-137, 2000. (Pubitemid 29439303)
7. Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML, Douc-Rasy S, Duvillard P, Armand JP and Riou G: High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases: absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10: 1217-1227, 1995.
8. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA and Sidransky D: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 712-717, 1995.
9. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T and Iggo R: Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 14: 163-169, 1997. (Pubitemid 27068302)
10. Van Oijen MGCT, Tilanus MGJ, Medema RH and Slootweg PJ: Expression of p21 (WafI/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 27: 367-375, 1998. (Pubitemid 28407832)
11. Gallo O, Chiarelli I, Boddi V, Bocciolini C, Bruschini L and Porfirio B: Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. Int J Cancer 84: 573-579, 1999.
12. Ralhan R, Agarwal S, Nath N, Mathur M, Wasylyk B and Srivastava A: Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population. Oral Oncol 37: 243-250, 2001. (Pubitemid 32245848)
13. Kerdpon D, Sriplung H and Kietthubthew S: Expression of p53 in oral squamous cell carcinoma and its association with risk habits in Southern Thailand. Oral Oncol 37: 553-557, 2001. (Pubitemid 32889616)
14. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JTC and Cheng AJ: Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 22: 1497-1503, 2001.
15. Bradley G, Irish J, MycMillan C, Mancer K, Witterick I, Hartwick W, Gullane P, Kamel-Reid S and Benchimol S: Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene 20: 654-658, 2001.
16. Schildt EB, Nylander K, Eriksson M, Hardell L, Magnusson A and Roos G: Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Int J Oncol 22: 861-868, 2003.
17. Calzolari A, Chiarelli I, Bianchi S, Messerini L, Gallo O, Porfirio B and Mattiuz PL: Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Pathol 107: 7-11, 1997. (Pubitemid 27104629)
18. Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R and Moriuchi T: High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 15: 2667-2674, 1997. (Pubitemid 27507614)
19. Hogmo A, Borresen-Dale AL, Blegen H, Lindholm J, Kuylenstierna R, Auer G and Munck-Wikland E: TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas. Anticancer Res 19: 3433-3438, 1999. (Pubitemid 30000199)
20. Hauser U, Balz V, Carey TE, Grenman R, van Lierop A, Scheckenbach K and Bier H: Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 24: 868-873, 2002. (Pubitemid 34913258)
21. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS and Gluckman JL: The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 119: 1118-1122, 1993. (Pubitemid 23303092)
22. Wiest T, Schwartz E, Enders C, Flechtenmacher C and Bosch FX: Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perrurbed pRb cell cycle control. Oncogene 21: 1510-1517, 2002. (Pubitemid 34226138)
23. Hogmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J and Auer G: Nuclear DNA content and p53 immunostaining in metachronous preneoplastic lesions and subsequent carcinomas of the oral cavity. Head Neck 18: 433-440, 1996. (Pubitemid 26268842)
24. Tjebbes GWA, Leppers van der Straat FGJ, Tilanus MGJ, Hordijk GJ and Slootweg PJ: P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases Oral Oncol 35: 384-389, 1999.
25. Frank JL, Bur ME, Garb JL, Kay S, Ware JL, Sismanis A and Neifeld JP: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73: 181-186, 1994.
26. Gallo O and Bianchi S: p53 expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract. Eur J Cancer 31B: 53-57, 1995.
27. Awwad S, Jaros E, Somes J and Lunec J: P53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys 34: 323-332, 1996. (Pubitemid 26031577)
28. Hogmo A, Kuylenstierna R, Lindholm J, Nathansson A, Auer G and Munck-Wikland E: Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas. Mol Pathol 51: 268-272, 1998. (Pubitemid 28480344)
29. Hogmo A, Kuylenstierna R, Lindholm J and Munck-Wikland E: Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for stage I tongue carcinomas. J Clin Pathol 52: 35-40, 1999. (Pubitemid 29023505)
30. Gallo O, Chiarelli I, Bianchi S, Calzolari A, Simonetti L and Porfirio B: Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer. Clin Cancer Res 2: 1577-1582, 1996. (Pubitemid 126447453)
31. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Bron L, Benhattar J, Tada M, van Meir EG, Estreicher A and Iggo RD: A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92: 3963-3967, 1995.
32. Smardova J, Vagunda V, Jandakova E, Vagundova M, Koukalova H, Kovarik J and Zaloudik J: p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry. Neoplasma 46: 384-389, 1999. (Pubitemid 30111131)
33. Smardova J, Nemajerova A, Trbusek M, Vagunda V and Kovarik J: Rare somatic p53 mutation identified in breast cancer: a case report. Tumor Biol 22: 59-66, 2001. (Pubitemid 32010738)
34. Pavlova S, Mayer J, Koukalova H and Smardova J: High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast. Int J Oncol 23: 121-131, 2003.
35. Ishioka C, Frebourg T, Yan YX, Vidal M, Friend SH, Schmidt S and Iggo R: Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5: 124-129, 1993. (Pubitemid 23293446)
36. Nakano Y, Naoe T, Kiyoi H, Kitamura K, Minami S, Miyawaki S, Asou N, Kuriyama K, Kusumoto S, Shimazaki C, Akiyama H, Saito K, Nishimura M, Motoji T, Shinagawa K, Saito H and Olino R: Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia. Eur J Haematol 65: 23-31, 2000. (Pubitemid 30432017)
37. Resnick MA and Inga A: Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc Natl Acad Sci USA 100: 9934-9939, 2003. (Pubitemid 37087046)